FDA on PROMs. Two important points
BMJ
.
2010 Oct 5:341:c5454.
doi: 10.1136/bmj.c5454.
Authors
D Rowen
,
J Carlton
,
J E Brazier
,
B Mulhern
,
S Palfreyman
,
K Stevens
,
A Tsuchiya
PMID:
20923843
DOI:
10.1136/bmj.c5454
No abstract available
Publication types
Letter
Comment
MeSH terms
Health Status
Humans
Outcome Assessment, Health Care*
Patient Satisfaction*
Practice Guidelines as Topic*
United States
United States Food and Drug Administration